S
TARO

SignatureFD’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

SignatureFD’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,323
Closed -$56K – 3286
2024
Q1 		$56K Sell
1,323
-4
-0.3% -$168 ﹤0.01% 1485
2023
Q4 		$55.4K Sell
1,327
-9
-0.7% -$332 ﹤0.01% 1401
2023
Q3 		$50.4K Sell
1,336
-3
-0.2% -$113 ﹤0.01% 1393
2023
Q2 		$50.8K Buy
1,339
+469
+54% +$14.7K ﹤0.01% 1420
2023
Q1 		$21.2K Sell
870
-29
-3% -$846 ﹤0.01% 1840
2022
Q4 		$26.1K Sell
899
-474
-35% -$14.1K ﹤0.01% 1671
2022
Q3 		$41K Buy
1,373
+1,002
+270% +$34.5K ﹤0.01% 1378
2022
Q2 		$13K Sell
371
-962
-72% -$36.7K ﹤0.01% 2013
2022
Q1 		$58K Sell
1,333
-193
-13% -$9.02K ﹤0.01% 1302
2021
Q4 		$76K Buy
1,526
+925
+154% +$51.8K ﹤0.01% 1151
2021
Q3 		$38K Buy
601
+252
+72% +$17.4K ﹤0.01% 1456
2021
Q2 		$25K Buy
349
+42
+14% +$3.08K ﹤0.01% 1632
2021
Q1 		$23K Sell
307
-7
-2% -$531 ﹤0.01% 1525
2020
Q4 		$23K Buy
314
+16
+5% +$1.03K ﹤0.01% 1412
2020
Q3 		$16K Buy
298
+192
+181% +$11.9K ﹤0.01% 1477
2020
Q2 		$7K Sell
106
-53
-33% -$3.55K ﹤0.01% 1712
2020
Q1 		$10K Buy
159
+138
+657% +$10.2K ﹤0.01% 1493
2019
Q4 		$2K Sell
21
-49
-70% -$4.13K ﹤0.01% 1950
2019
Q3 		$5K Buy
70
+49
+233% +$3.98K ﹤0.01% 1631
2019
Q2 		$2K Hold
21
– – ﹤0.01% 1805
2019
Q1 		$2K Sell
21
-12
-36% -$1.2K ﹤0.01% 1810
2018
Q4 		$3K Sell
33
-48
-59% -$4.63K ﹤0.01% 1684
2018
Q3 		$8K Hold
81
– – ﹤0.01% 1446
2018
Q2 		$9K Sell
81
-222
-73% -$24.4K ﹤0.01% 1421
2018
Q1 		$30K Buy
+303
New +$30.7K ﹤0.01% 924
2016
Q4 		– Sell
-153
Closed -$17K – 1300
2016
Q3 		$17K Buy
153
+129
+538% +$17.1K ﹤0.01% 877
2016
Q2 		$3K Sell
24
-2
-8% -$284 ﹤0.01% 1196
2016
Q1 		$4K Buy
+26
New +$3.69K ﹤0.01% 1067

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

SignatureFD's TARO Position: Q2 2024 in Review

SignatureFD sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 1,323 shares — an estimated $56K sold.

SignatureFD first reported a position in TARO in Q1 2016 and held it in 28 quarters. The position peaked at $76K in Q4 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • SignatureFD reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 1,323 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $56K.
  • SignatureFD first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 28 quarters.
  • SignatureFD's Taro Pharmaceutical Industries Ltd. position peaked at $76K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.